A Family-Centered Sexual Health Intervention to Promote Cervical Cancer Screening Uptake Among Low-Income Rural Women in India: Protocol for a Community-Based Mixed Methods Pilot Study.

India cancer cancer screening cervical cervical cancer screening family-centered care health literacy human papillomavirus human papillomavirus self-sampling low income rural rural area screening sexual health sexual health literacy sexually transmitted infection women

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
08 Sep 2022
Historique:
received: 20 11 2021
accepted: 03 05 2022
revised: 08 04 2022
entrez: 8 9 2022
pubmed: 9 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Human papillomavirus (HPV) is the primary cause of cervical cancer, which is preventable through screening and early treatment. The Papanicolaou (Pap) test and visual inspection with acetic acid (VIA), which are traditionally performed in clinical settings, have been used effectively to screen for cervical cancer and precancerous changes and reduce cervical cancer mortality in high-income countries for many decades. However, these screening methods are not easily accessible to women living in low- and middle-income countries, especially women living in rural areas. The project will use HPV self-sampling, which will be supported by a sexual health literacy intervention, to increase rural women's participation in cervical cancer screening. The objectives are to determine the effectiveness of this program in (1) increasing sexual health literacy, (2) reducing the gendered stigma of HPV and cervical cancer, and (3) promoting cervical cancer screening by using HPV self-sampling. The pilot study will use a community-based, family-centered, mixed methods design. We will recruit 120 women aged 30 to 69 years who are underscreened or were never screened for cervical cancer, along with 120 supportive male relatives or friends from 3 low-income rural/tribal villages in Maharashtra, India. Participants will attend gender-specific sexual health education sessions, followed by a movie matinee. Data will be collected through an interviewer-administered questionnaire before and after sexual health education sessions. The questionnaire will include items on social demographics, medical histories, attitudes, sexual health stigma, cervical cancer knowledge, and screening practices. Women will self-select whether to use HPV self-sampling. Those who do not may undergo a Pap test or VIA. Participants' views regarding barriers and facilitators and their suggestions for improving access and uptake will also be elicited. This protocol was approved by the research ethics boards of Toronto Metropolitan University (formerly known as Ryerson University; reference number: REB 2020-104) and Tata Memorial Center (reference number: OIEC/3786/2021 /00003). The Preventing Cervical Cancer in India Through Self-Sampling study was funded in January 2020 for 15 months. Due to the COVID-19 pandemic, the project was extended by 1 year. The study outcome measures will include changes in knowledge and attitudes about cervical cancer screening, the proportion of participants who self-select into each cohort, the proportion of positive test results in each cohort, and the proportion of participants with confirmed cervical cancer. Women's experiences regarding barriers and facilitators of screening uptake will be captured. Our multifaceted work could lead to reduced cervical cancer mortality and morbidity and increased community capacity in sexual health promotion and cervical cancer prevention. The insights and lessons learned from our project can be used to inform the adaptation and scale-up of HPV self-sampling among women across India and in other countries; promote collective commitment to family-centered wellness; and support women to make healthful, personalized cervical screening decisions. PRR1-10.2196/35093.

Sections du résumé

BACKGROUND BACKGROUND
Human papillomavirus (HPV) is the primary cause of cervical cancer, which is preventable through screening and early treatment. The Papanicolaou (Pap) test and visual inspection with acetic acid (VIA), which are traditionally performed in clinical settings, have been used effectively to screen for cervical cancer and precancerous changes and reduce cervical cancer mortality in high-income countries for many decades. However, these screening methods are not easily accessible to women living in low- and middle-income countries, especially women living in rural areas.
OBJECTIVE OBJECTIVE
The project will use HPV self-sampling, which will be supported by a sexual health literacy intervention, to increase rural women's participation in cervical cancer screening. The objectives are to determine the effectiveness of this program in (1) increasing sexual health literacy, (2) reducing the gendered stigma of HPV and cervical cancer, and (3) promoting cervical cancer screening by using HPV self-sampling.
METHODS METHODS
The pilot study will use a community-based, family-centered, mixed methods design. We will recruit 120 women aged 30 to 69 years who are underscreened or were never screened for cervical cancer, along with 120 supportive male relatives or friends from 3 low-income rural/tribal villages in Maharashtra, India. Participants will attend gender-specific sexual health education sessions, followed by a movie matinee. Data will be collected through an interviewer-administered questionnaire before and after sexual health education sessions. The questionnaire will include items on social demographics, medical histories, attitudes, sexual health stigma, cervical cancer knowledge, and screening practices. Women will self-select whether to use HPV self-sampling. Those who do not may undergo a Pap test or VIA. Participants' views regarding barriers and facilitators and their suggestions for improving access and uptake will also be elicited. This protocol was approved by the research ethics boards of Toronto Metropolitan University (formerly known as Ryerson University; reference number: REB 2020-104) and Tata Memorial Center (reference number: OIEC/3786/2021 /00003).
RESULTS RESULTS
The Preventing Cervical Cancer in India Through Self-Sampling study was funded in January 2020 for 15 months. Due to the COVID-19 pandemic, the project was extended by 1 year. The study outcome measures will include changes in knowledge and attitudes about cervical cancer screening, the proportion of participants who self-select into each cohort, the proportion of positive test results in each cohort, and the proportion of participants with confirmed cervical cancer. Women's experiences regarding barriers and facilitators of screening uptake will be captured.
CONCLUSIONS CONCLUSIONS
Our multifaceted work could lead to reduced cervical cancer mortality and morbidity and increased community capacity in sexual health promotion and cervical cancer prevention. The insights and lessons learned from our project can be used to inform the adaptation and scale-up of HPV self-sampling among women across India and in other countries; promote collective commitment to family-centered wellness; and support women to make healthful, personalized cervical screening decisions.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
PRR1-10.2196/35093.

Identifiants

pubmed: 36074549
pii: v11i9e35093
doi: 10.2196/35093
pmc: PMC9501679
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e35093

Informations de copyright

©Mandana Vahabi, Aisha K Lofters, Gauravi Mishra, Sharmila Pimple, Josephine Pui-Hing Wong. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.09.2022.

Références

PLoS One. 2018 Aug 10;13(8):e0200920
pubmed: 30096147
CMAJ. 2007 Aug 28;177(5):480-3
pubmed: 17724326
Br J Cancer. 2015 Feb 17;112(4):667-75
pubmed: 25633037
Cult Health Sex. 2013;15(1):15-28
pubmed: 23140182
Prev Med. 2014 Jul;64:108-13
pubmed: 24736093
J Natl Cancer Inst. 2014 Mar;106(3):dju009
pubmed: 24563518
BMC Womens Health. 2019 Aug 8;19(1):107
pubmed: 31395060
BMC Public Health. 2016 Aug 24;16(1):868
pubmed: 27557928
Indian J Gend Stud. 1997 Jan-Jun;4(1):51-65
pubmed: 12321023
Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):769-72
pubmed: 25713024
Br J Cancer. 2011 Mar 15;104(6):915-20
pubmed: 21343937
J Transcult Nurs. 2015 Sep;26(4):346-53
pubmed: 24829264
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
CMAJ. 2016 Sep 6;188(12):853-854
pubmed: 27114490
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
Int J Cancer. 2013 Jul;133(1):164-71
pubmed: 23233356
J Fam Plann Reprod Health Care. 2015 Jan;41(1):38-47
pubmed: 24521934
Lancet Oncol. 2018 Oct;19(10):1289-1306
pubmed: 30219626
Am J Health Promot. 1992 Jan-Feb;6(3):197-205
pubmed: 10146784
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1960-9
pubmed: 21752985
J Med Screen. 2004;11(2):85-8
pubmed: 15153323
Eval Health Prof. 2015 Mar;38(1):15-20
pubmed: 25015082
SAHARA J. 2015;12:87-105
pubmed: 26726756
PLoS Med. 2008 Jun 17;5(6):e132
pubmed: 18563963
BMC Womens Health. 2015 Oct 12;15:82
pubmed: 26458898
BMJ Open. 2011 Feb 26;1(1):e000030
pubmed: 22021733
Can J Public Health. 2013 Feb 11;104(2):e159-66
pubmed: 23618210
Indian J Med Res. 2018 Dec;148(6):687-696
pubmed: 30778002
South Asian J Cancer. 2020 Jul;9(3):141-146
pubmed: 33937136
Int J Womens Health. 2015 Apr 16;7:405-14
pubmed: 25931830
Sex Transm Infect. 2006 Aug;82(4):337-9
pubmed: 16877589
Appl Nurs Res. 2016 May;30:58-60
pubmed: 27091254
Int J Cancer. 2013 Dec 1;133(11):2681-7
pubmed: 23712523
AIDS Behav. 2014 Mar;18(3):595-604
pubmed: 23686152
J Dev Econ. 2011 Jan 1;94(1):1-17
pubmed: 24319310
Stud Fam Plann. 2001 Sep;32(3):189-213
pubmed: 11677692

Auteurs

Mandana Vahabi (M)

Daphne Cockwell School of Nursing, Toronto Metropolitan University (formerly known as Ryerson University), Toronto, ON, Canada.

Aisha K Lofters (AK)

Women's College Hospital, Toronto, ON, Canada.

Gauravi Mishra (G)

Tata Memorial Centre, Maharashtra, India.

Sharmila Pimple (S)

Tata Memorial Centre, Maharashtra, India.

Josephine Pui-Hing Wong (JP)

Daphne Cockwell School of Nursing, Toronto Metropolitan University (formerly known as Ryerson University), Toronto, ON, Canada.

Classifications MeSH